Concepedia

Ivana Šestak

IŠ

60

Publications

10.2K

Citations

39

H-Index

2006

Active since

Affiliations

Queen Mary University of London(Current)

Royal Marsden Hospital

Breast Cancer Now

Cancer Research UK

Institute of Cancer Research

Ivana Šestak is an author at Queen Mary University of London specializing in medicine, breast cancer, and oncology.

ORCID

Top concepts

Publications per year

2006–2022

60

Publications

60

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

Jack Cuzick, Ivana Šestak, Michael Baum et al. · The Lancet Oncology · 2010 · 1.7K citations

, , +8

Comparison of PAM50 Risk of Recurrence Score With Onco<i>type</i> DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy

Mitch Dowsett, Ivana Šestak, Elena López‐Knowles et al. · Journal of Clinical Oncology · 2013 · 632 citations · Full text

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

Jack Cuzick, Ivana Šestak, John Forbes et al. · The Lancet · 2013 · 578 citations · Full text

, , +11

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

Jack Cuzick, Ivana Šestak, Sarah E. Pinder et al. · The Lancet Oncology · 2010 · 564 citations · Full text

Development and verification of the PAM50-based Prosigna breast cancer gene signature assay

Brett Wallden, James J. Storhoff, Torsten O. Nielsen et al. · BMC Medical Genomics · 2015 · 543 citations · Full text

Rows per page

1–5 of 60